Académique Documents
Professionnel Documents
Culture Documents
in a Nutshell
Christian Chaussy, Geert Tailly, Bernd Forssmann, Christian
Bohris, Andreas Lutz, Martine Tailly-Cusse, Thomas Tailly
Christian Chaussy
Prof. of Urology
University of Regensburg, Germany
cgchaussy@gmail.com
Geert G. Tailly, MD, FEBU
Head of the Department of Urology
AZ Klina, Brasschaat, Belgium
geert.tailly@klina.be
Bernd Forssmann, Dr.
Herrsching, Germany
Christian Bohris, Dr.
Project Leader, Dornier MedTech Systems GmbH,
Wessling, Germany
Andreas Lutz, Dr.
Program Manager, Dornier MedTech Systems GmbH,
Wessling, Germany
Martine Tailly-Cusse
Specialty nurse Endourology & ESWL
AZ Klina, Brasschaat, Belgium
Thomas Tailly, MD
Department of Urology, UZ KU Leuven, Belgium
Contents
1 Introduction
2
2.1
2.2
2.3
2.4
Lithotripter design
Shock wave generator
Localization system
Patient positioning
Integrated endourology concept
3
3.1
3.2
3.3
3.4
3.5
9
9
10
10
11
4 Indications
4.1 Renal stone treatment
4.1.1 General recommendation
4.1.2 Special recommendation for lower pole stones
4.2 Ureteral stones
4.3 Special indications
4.3.1 Paediatric urolithiasis
4.3.2 Obesity
4.3.3 Renal anomalies
4.4 Stone composition
23
23
23
23
24
24
25
25
26
26
5 Contraindications
27
VI
Contents
6
How to perform ESWL?
6.1 Device preparation
6.2 Pain management
6.3 Patient preparation
6.4 Positioning
6.5 Stone targeting
6.5.1 X-ray guided ESWL
6.5.2 Ultrasound guided ESWL
6.6 Coupling
6.7 Shock wave application treatment parameters
6.7.1 Kidney stones
6.7.2 Ureteral stones
6.8 Paediatric urolithiasis
6.8.1 Anesthesia
6.8.2 Paediatric positioning aid
6.8.3 Lung protection
6.8.4 Imaging
6.8.5 Adapted shock wave parameters
29
29
30
31
32
33
34
35
38
40
40
42
42
42
43
43
43
44
7 Follow-up
7.1 Stone clearance
7.2 Stone analysis prevention of new stone formation
7.3 Complications
7.3.1 Subcapsular haematoma
7.3.2 Septicaemia
7.4 Long-term complications
45
45
46
46
46
47
48
8 Summary
48
9 Literature
49
1 Introduction
Following extensive research that started as early as in 1974, the first
extracorporeal shockwave lithotripsy (ESWL) treatment of a human was
performed on February 07, 1980 by Christian Chaussy, Dieter Jocham and
Bernd Forssmann using a prototype Dornier HM1 (Dornier Human Model1,
see Fig. 1-1) lithotripter [1]. The first serial Dornier HM3 (Dornier Human
Model 3) was installed in 1983 at the Katharinen Hospital in Stuttgart and in
March 1984 the first Dornier HM3 in the US was installed at the Methodist
Hospital in Indianapolis. The results with this new treatment modality were
so successful, that it thoroughly revolutionized modern stone management.
A rapid expansion of indications encompassing urinary stones of all sizes at
all levels of the urinary tract made ESWL the treatment of choice for almost
any urolithiasis.
1 Introduction
Primarily due to the high capital investment for a Dornier HM3 ESWL
originally remained the privilege of high volume stone centers with urologists
heavily trained in the practice of ESWL. With the introduction of less
expensive second and third generation lithotripters the practice of ESWL
became available to more and also smaller centers. This rapid propagation
of extracorporeal shockwave lithotripsy in ever smaller centers inevitably
resulted in dilution of experience and poorer results with ESWL. As the newer
lithotripters also proved easier to operate than the Dornier HM3, they were
considered plug and play and proper training in ESWL more often than not
was neglected leading to a further deterioration in results. As a consequence
the pendulum swung in favour of endoscopic techniques (URS, RIRS, PNL).
Although these techniques demand a high level of skill and expertise, these
were and still are provided in extensive and intensive training programs. This
is in sharp contrast to the often substandard training in ESWL, still the least
invasive treatment modality for any urinary stone. With proper equipment, an
understanding of the basic physics of shock waves and adequate training in
the safe application of shock wave energy, results are excellent with minimal
complications. In order to achieve optimal treatment results with ESWL,
an understanding of the underlying physical mechanisms and a knowledge
of the necessary treatment protocols are therefore essential. The purpose of
this brochure is to inform the user about the physical principles behind the
technology and to offer practical guidance on performing ESWL.
2 Lithotripter design
All lithotripters basically consist of three components: a shock wave generating
system, a localization system for identifying and localizing the stone and a
positioning system used to position the stone in the shock wave focus, where
the shock wave intensity is the highest. When the three components are used
in the right combination, the stone can be fragmented. Next to these three
essential systems, additional components for controlling, monitoring and
documentation (See Fig. 2-1) are incorporated in most models.
2.1 Shock wave generator
The shock wave generator, the most important component of any lithotripter,
generates the shock waves and aims them at the focus by means of a focussing
unit, such as a lens. Water is necessary to efficiently transfer the shock waves
into the patient as it has acoustic properties similar to those of tissue. In the
HM3, coupling between the generator and the tissue is achieved directly by
means of a water bath in which the patient is placed. This coupling is ideal
because there are no disturbing structures to inhibit the propagation of shock
waves. In the new units, the shock waves are transferred into the patient via
a coupling cushion. For ESWL to be successful the coupling must be lossfree. Shock wave energy is a key parameter in stone disintegration, while
energy flux density relates to the cause of renal side effects. Therefore, the
new systems are optimized for high energy in order to deliver the maximum
level of energy to the stone with minimal tissue trauma. The penetration
depths have been extended to 17 cm, which makes it possible to treat obese
patients. Today, most lithotripters are equipped with electromagnetic shock
wave systems (detailed information is provided in chapter 3).
10
2 Lithotripter design
11
Fig. 2-1: Modern urological workstation for ESWL and endourology (Dornier Gemini).
Shock wave unit (a), patient positioning system (b), X-ray localization system with C-arm (c),
Flat Panel Detector (FPD) (d) and X-ray tube (e), isocentric ultrasonic localization arm (f).
12
13
Fig. 3-1: Schematic illustration of a longitudinal wave. The curve represents pressure or
density as a function of space. In a homogeneous medium the waves produce areas of periodic
compression and decompression. This is illustrated by the distribution of volume elements
showing dense and expanded regions.
14
Fig. 3-2: Principles of shock wave generators used in lithotripters (See text for description).
Left: Electro-Magnetic Shock wave Emitter (EMSE). Centre: Electrohydraulic shock wave
emitter. Right: Piezoelectric shock wave emitter.
3.1.1 Electromagnetic
The main component of an electromagnetic shock wave source is the ElectroMagnetic Shock wave Emitter (EMSE). The EMSE is driven by a high voltage
electric pulse that causes a rapid movement of the EMSEs membrane. This
rapid forward movement of the membrane creates a planar acoustic pulse
that is focused by an acoustic lens and transmitted to the patient through a
water-filled bellow.
3.1.2 Electrohydraulic
The main components of an electrohydraulic shock wave generator are the
electrode, which is also referred to as spark plug, and an ellipsoidal reflector.
The underwater spark gap discharge between the tips of the electrode causes
rapid local vaporization to occur in the water, which generates a high-amplitude
pressure pulse. To focus the initial radial wave, the electrode is located at the
focal point F1 of the ellipsoidal reflector. The shock wave is reflected by the
walls of the ellipsoid creating a focused shock wave in the focal zone F2.
3.1.3 Piezoelectric
Piezoelectric crystals expand rapidly when a high voltage electrical pulse is
applied to them. In piezoelectric shock wave generators, a large number of
piezoelectric crystals are synchronously excited, which creates a pressure
wave. Focusing is accomplished by arranging the piezoelectric crystals in a
spherical shape.
15
Fig. 3-3: Shock wave pressure pulse as function of time measured in the shock wave focal
zone F2.
16
Fig. 3-4: Curve illustrating the focus width (showing the -6 dB focus).
17
18
19
20
3
Fig. 3-7: Hopkinson effect.
The grey circle represents a stone. The incoming shock wave (1), travelling from left to right,
is split at the front stone surface into a reflected (2) and transmitted (3) component. At the rear
stone surface, the shock wave (3) is again partially reflected, resulting in a high-amplitude
negative pressure wave (4).
21
3.4.4 Cavitation
Every shock wave pulse has a trailing negative pressure phase. Its tensile
forces create microbubbles in liquids like urine or blood. These cavitation
bubbles are unstable and collapse with a rapid implosion (See Fig. 3-8).
The associated liquid jets cause a pitting of adjacent structures like stones.
Cavitation increases with shock wave frequency and intensity.
Fig. 3-8: Image sequence of a solid target exposed to a shock wave propagating from left to
right. The second frame shows individual cavitation bubbles within the water and a bubble
cluster on the face of the target. Whereas the single cavitation bubbles collapse quite early,
the cluster grows further until it collapses, revealing an intermediate mushroom-like shape
(680s).
22
Cavitation, which may occur for example inside blood vessels or in the urinefilled collecting system of the kidney, can cause vessel and parenchymal
damage resulting in bleeding and haematomas. Recent literature shows that
the risk of cavitation-induced renal damage increases with high shock wave
frequencies and excessive intensities. When a shock wave passes through
tissue it may strike cavitation bubbles created by a previous shock wave
pulse. This has two effects:
The shock wave energy is partly blocked by the cavitation bubbles so
that the stone is exposed to reduced shock wave energy (SeeFig.3-9).
The shock wave interfering with cavitation bubbles can create forced
bubble collapse, which increases the risk of side effects.
As a result, stone disintegration is impaired and the risk of side effects is
increased.
Gas-filled organs, particularly the lung, are at high risk of severe tissue
damage when exposed to shock waves. When shock waves reach the tissue/
gas interface, they are reflected, and the reflected shock wave is reversed
in polarity (See also Hopkinson Effect). The resulting tensile forces at the
interface can cause organ rupture (See Fig. 3-9).
Fig. 3-9: Left: Blocking effect of a cavitation bubble field. Cavitation bubbles within the shock
wave path cause an attenuation of the shock wave. Compared to the undisturbed situation, the
shock wave pressure amplitudes are lowered (See blue curves). Right: Reflection at a tissue/
air interface. The incoming shock wave (blue) is fully reflected. Due to the transition from the
positive pulse into a negative pulse this region is exposed to strong tensile forces.
23
4 Indications
ESWL is a non-invasive treatment modality for stones in the entire urinary
tract. With modern lithotripters all portions of the urinary tract are accessible.
Major advantages of ESWL over other procedures are: It is the least invasive
treatment modality for urolithiasis. In the majority of cases it does not require
anaesthesia. Generally, analgosedation is used for pain management. ESWL
is very safe with a very low risk of side effects and serious complications.
Despite ESWLs potential as a universal method for stone treatment, selecting
the right patients and stone locations is a prerequisite for success. For patients
with normal renal anatomy and stones located in the renal pelvis and the
upper and middle calyx up to a size of 20 mm, shock wave lithotripsy is the
preferred treatment modality.
4.1 Renal stone treatment
4.1.1 General recommendation
With the introduction of the Dornier HM3 in the 1980s, ESWL became the
treatment of choice for kidney stones. This is reflected in current EAU and
AUA Guidelines [5, 6]. For the removal of radiopaque (calcium) and cystine
stones with a maximum diameter of 20 mm, ESWL is recommended as the
first-line therapy.
4.1.2 Special recommendation for lower pole stones
For lower calyx stones there is an ongoing debate about the efficacy of ESWL.
Several clinical trials have shown that the stone-free rate after ESWL of lower
calyx stones is worse than for stones in other parts of the renal system. In 1992,
Sampaio et al. already reported that an acute lower pole infundibulopelvic
angle, a narrow infundibular width, and a long infundibular length may
predict a decreased stone-free rate. However, Danuser et al. (2007) could not
find any significant anatomical influence on the clearance of disintegrated
stones from the lower calyx. In the lower pole study 1 by Albala et al. (2001)
a cumulative stone-free rate of 37% for ESWL versus 95% for percutaneous
nephrostolithotomy (PNL) was reported.
24
On the other hand, Obek et al. (2001) and Riedler et al. (2003) reported
cumulative stone-free rates of 63% and 65.5% for lower pole calculi treated
with second- and third-generation lithotripters. Obek could not find significant
differences in treatment outcomes for stones in lower, middle or upper calices.
Pearle et al. (2005) compared ESWL and ureteroscopic lithotripsy (URS) for
treatment of small lower pole stones. In a randomized multicenter study they
could not find a significant difference in stone-free rates. ESWL, however,
was associated with greater patient acceptance and shorter convalescence.
4 Indications
25
26
In obese patients the main problem is the proper targeting and focussing
of the stones. Therefore lithotripters with high resolution imaging systems,
versatile coupling of the therapy head above and under table, and above all
a SW-source with a penetration depth of up to 17 cm are expected to yield
better results.
Experienced operators also use simple positioning tricks to improve targeting
in obese patients.
4.3.3 Renal anomalies
27
5 Contraindications
Since ESWL was first introduced in 1980, its range of indications rapidly
expanded to include most stones at all levels of the urinary tract. International
EUA / AUA Guidelines [5, 6] consider ESWL to be the primary treatment
modality for most stone types.
The following conditions are absolute contraindications, and patients who
have them should be considered for alternative treatment modalities:
Pregnancy
Untreated coagulation abnormalities
Continued use of anticoagulants prior to ESWL
Pulmonary tissue in the shock wave path
Tumour in the shock wave path
Aneurysms in the shock wave path
Pathological changes in the shock wave path
Active pyelonephritis
Pregnancy remains an absolute contraindication due to the possible use of
fluoroscopy but above all due to the possible adverse effects of the shock
wave on the foetus.
Given that untreated coagulation abnormalities dramatically increase the
risk of large perirenal and subcapsular haematomas, they are an absolute
contraindication for ESWL. The influence of medications containing
acetylsalicylic acid is under discussion. Most of the available publications
recommend a break of four to seven days.
Untreated hypertension is considered a relative contraindication and should
be regulated before treatment.
28
29
30
31
32
6.4 Positioning
6.4 Positioning
Patient movements during shock wave application and respiration cause
the stone to move out of the shock wave focus and are detrimental to stone
disintegration. Therefore, a stable patient position is essential for good disinte
gration results. Since the treatment typically takes about 30 to 45 minutes,
the patient requires a comfortable position. A neck roll, knee roll, a wedge
or arm rests are accessories that help to stabilize the patients position. If
possible, the supine patient position is preferred, since it is more comfortable
for the patient and offers better access to the patient for the anaesthetist when
doing general anaesthesia.
With a lithotripter offering both under-table and over-table therapy head
positions, the patient can be treated in a supine position for all stone locations
(See Fig. 6-1). Stones in the kidney and upper ureters down to the iliac crest
are treated with the therapy head coupled in the dorsal or dorsolateral location.
Since the iliac crest blocks the shock waves, stones in the distal ureter require
a ventral or ventrolateral therapy head position. If the lithotripter only permits
under-table therapy head positions, the patient needs to be positioned prone
for ureteral stones distal to the iliac crest.
Fig. 6-1: Dornier Gemini lithotripter. Left: Set-up for stone treatment in left kidney. The
therapy head (indicated by an arrow) is coupled from dorsolateral. Right: Setup for stone
treatment in right lower ureter. The therapy head is coupled from the ventrolateral position.
It is advisable to pre-position the patient in such a way that the stone is already
in close proximity to the focus. This will avoid time-consuming moves later
in the procedure.
33
Fig. 6-2: Left: Native X-ray image with radiopaque stone within the crosshairs. The
lithotripter coupling cushion of the therapy head is shading the right side. Right: Ultrasound
image of a kidney stone. Within the crosshairs it is displayed by its bright stone reflection. It is
accompanied by an acoustic shadow behind the reflection.
Calcium oxalate and calcium phosphate stones are radiopaque and have a
high density. Struvite, mixed and cystine stones have a lower density but are
still visible on native X-ray images. Uric acid stones are radio-translucent and
can only indirectly be visualized by X-ray using a contrast agent.
34
With ultrasound stones are visualized by a bright echo marking the stone
surface regardless of the stones chemical composition. The characteristic
acoustic shadow behind the bright stone reflection distinguishes a stone
from other bright structures such as blood vessels or a stent. Ultrasound is
unsuitable for visualization of ureteral stones unless they are very proximal
in a dilated system or pre-vesical where the bladder serves as an acoustic
window. In the middle section of the ureter, ultrasound scanning cannot be
used to locate stones, since anatomical landmarks are missing and intestinal
gas and bone interfere (See Fig. 6-3).
Fig. 6-3: Ultrasound imaging is appropriate for kidney stones, proximal and distal ureteral
stones.
35
Initially, the full image area is used to confirm the position of the stone taking
into account visible landmarks like the spine and ribs. Once the stone has
been identified and is located in the shockwave focus, the imaged region
of interest has to be reduced in size by closing the X-ray collimator. This
effectively reduces the patients radiation exposure.
Since the target may get out of the shock wave focus due to patient movement
or stone movement within the patient, stone positioning must be reconfirmed
at regular intervals. If there is an apparent patient movement, stone targeting
must be checked immediately after the patient has returned to a stable
position. Otherwise imaging may be repeated, for example: every 300-500
shock waves. Even though stone movements are more likely within the
coronal plane, imaging should not rely solely on the vertical C-arm position.
Especially in the beginning of the treatment and if the position was corrected
in the coronal plane, the ventrodorsal axis should be checked with the angled
C-arm position.
During ESWL treatment, the degree of stone disintegration may be assessed
by direct signs (cracks in the stone, visualisation of multiple fragments) or
indirect signs (loss of density, softening of the margins).
Target the stone in both image projection planes (PA and CC).
Stone targeting must be reconfirmed at regular intervals.
Reduce the image size for monitoring (reduction of radiation
exposure).
36
37
Fig. 6-4: Ultrasound monitoring of the contact zone with an inline transducer.
Left: A bubble is revealed by its bright echo (white arrow) and posterior shadow (black arrows).
Right: Image after removal of the bubble by wiping the cushion.
38
6.6 Coupling
6.6 Coupling
With most modern lithotripters, the shock waves are transmitted from the
shock wave source to the patient via a water-filled cushion. To achieve a good
transmission into the body, typically ultrasound gel is applied.
Various studies have shown that even a few air bubbles trapped in the gel
considerably reduce the effectiveness of the shock waves (See Fig. 6-5). In
particular, incomplete coupling or a cushion which does not fit snugly against
the body surface but has an air-filled wrinkle inevitably leads to ineffective
treatment.
6
Fig. 6-5: Reduction of disintegration capability by air trapped within the coupling zone. Results
from in vitro model stone tests (for details see Bohris et al. 2012). Test results are the number
of shock waves required for complete disintegration of the stone. Test was performed under
various coupling conditions. When 20% of the coupling area was blocked by air bubbles, about
three times the number of shock waves was needed as compared to the bubble-free condition.
Some tips help to obtain a bubble-free coupling and avoid poor coupling
conditions (See table).
39
Fig. 6-6: Left: Applying gel to the cushion. Right: Improving coupling by manually wiping the
cushion. During this procedure the inflation pressure and patient position should be maintained
so that the contact between bellows and skin is not lost.
40
If the lithotripter therapy head is equipped with an inline ultrasound unit, the
quality of coupling may be monitored (Fig. 6-4) and improved as needed.
Even more convenient is the use of a surveillance camera which is integrated
into the therapy head (See Fig. 6-7).
Fig. 6-7: Video monitoring of the coupling area. Left: Numerous bubbles (dark) are located
within the gel layer (bright). Right: Area after removal of the disturbances by wiping the
cushion.
The aim of ESWL is to disintegrate a stone into fragments that can pass
through the urinary tract system spontaneously. The disintegration improves
as the shock wave energy dose, which is the total shock wave energy applied
during one treatment, increases (See section 3.3). The energy dose must be
sufficient to achieve adequate stone fragmentation and clearance so that the
need for further procedures (re-ESWL, URS, PNL) is reduced. On the other
hand, overtreatment must be avoided since the risk of side effects is also
directly related to energy dose.
6.7.1 Kidney stones
Within a certain range the accumulated shock wave dose may be applied
using different energy settings. If a lower energy is chosen, though, this must
be compensated by applying a larger number of shock waves. It is generally
recommended to adjust the total dose and energy level to the individual
patient (obesity, risk factors) and stone characteristics (stone size, chemical
composition). Patient risk factors that require a lower shock wave dose are:
41
Untreated hypertension
Diabetes mellitus
Age > 65 years
Impaired renal function, hydronephrosis
Paediatric patients
Renal tissue damage and resulting haematoma can be caused by cavitation
(See section 3.4.4). The tensile stress of the shock wave may induce small
vapour bubbles in the blood. These bubbles are not stable but collapse after a
sub-second lifetime. Both bubble expansion and collapse are accompanied by
forceful stress to the proximity of the bubble which can damage the capillary
walls.
The risk of inducing cavitation within the renal parenchyma increases with
the energy level used. Various recent publications have indicated that the
occurrence of cavitation is strongly related to the pulse repetition frequency.
Lowering the pulse repetition frequency (PRF) is thus an effective way to
avoid renal vascular damage. In addition, a slower PRF will also improve
stone disintegration, since a blocking effect by cavitation is avoided (See
section 3.5).
A pre-treatment (100-500 shock waves) at low energy levels is recommended
to activate a protective effect in the kidney. Animal studies have shown that
shock waves reduce the glomerular filtration rate and the renal plasma flow in
the area exposed to the shock waves and even in the contralateral kidney due
to induced vasoconstriction.
If ESWL is performed with intravenous analgesia, it is a common practice in
any event to increase the energy stepwise in order to adapt the patient to the
shock waves. Operators who apply ESWL under full anaesthesia and start
immediately with high-power shock wave levels should switch their strategy
to a gradual energy increase in order to achieve better results.
42
43
Fig. 6-8: Positioning aid which supports the body at a table cut-out.
44
45
7 Follow-up
Stone clearance is monitored in follow-up examinations. Success is verified,
or auxiliary procedures are specified. Even though severe complications
induced by ESWL are rare, subcapsular haematomas or septicaemia can lead
to life-threatening conditions. Such complications must be identified and
properly treated.
7.1 Stone clearance
After stone disintegration by ESWL, episodes of ureteral colic during passage
of fragments are common (8-10%). Renal colic should be dealt with lege
artis. In case of (rapid onset) massive pain, an ultrasound exam is indicated to
rule out renal haematoma (See section 7.3.1).
In the treatment of kidney stones, colicky pain may be reduced and obstruction
may be avoided by stenting. The insertion of a stent prior to ESWL is advised
when the largest stone diameter exceeds 20 mm. However, routine stenting,
especially in the case of ureteral stones, is not recommended [5].
Pharmacological facilitation of fragment passage or medical expulsion
therapy (MET) can be accomplished by administering -receptor antagonists.
Tamsulosin is the commonly used compound, but other -blocking agents
appear to be similarly effective. MET is not recommended for the paediatric
population due to the limited data for that group.
Mechanical percussion and inversion therapy may enhance passage of
fragments, especially originating from the lower pole calyces.
In most cases, a plain X-ray (KUB) is taken to define the status of stone
clearance.
Stone-free rates are typically high in ureteral stones, even though repeated
ESWL treatment sessions are occasionally required.
In kidney stones, however, a substantial number of patients show residual
fragments. When those fragments are small and are without symptoms,
they are referred to as clinically insignificant residual fragments (CIRF) or
asymptomatic residual fragments (ARF). The number of patients who are
stone-free typically increases with time.
46
Therefore, most clinical reports do not report stone-free rates until after
3months. Final evacuation of CIRF or ARF from the lower pole calyx may
take up to 24 months. However, it must be noted that the management of
patients with residuals after ESWL is an area that is still broadly debated.
7.2 Stone analysis prevention of new stone formation
Measures to prevent new stone formation or to avoid growth of rest fragments
are mainly dependent of stone composition.
In order to provide the patients with advice regarding preventive measures to
avoid new stone episodes, it is therefore advisable to obtain a stone analysis
on the evacuated fragments if and whenever possible.
The full extent of medical therapy of different stone types is a vast chapter
and is beyond the scope of this booklet on the good practice of ESWL. We
refer to the literature [12].
7.3 Complications
Generally and especially in comparison with endoscopic techniques
complication rate following ESWL is extremely low.
Severe complications are extremely rare. Appropriate precautions need to be
taken to avoid them.
7.3.1 Subcapsular haematoma
The current EAU Guidelines [5] list the risk of symptomatic haematoma as
less than 1% and the risk of asymptotic haematoma as 4%. Diagnosis is based
on ultrasound or CT imaging. Clinical signs are abnormal pain following
SW treatment, bulging and/or tenderness of the flank region, tachycardia,
hypotension or signs of acute anaemia. The majority of manifested
haematomas can be treated with a conservative approach, including blood
transfusion in rare cases. Resorption may take 6 weeks to 6 months.
Although the risk of an induced haematoma cannot completely be eliminated,
it can be minimized when the ESWL is competently performed and patientspecific risk factors are identified and addressed.
7 Follow-up
47
48
8 Summary
8 Summary
ESWL is an excellent first-line treatment for the majority of patients with
urinary tract calculi, provided that the technique is appropriately applied.
Therefore, operators must be properly educated and trained to ensure
the success of ESWL. This booklet focusses on the basic principles and
practical aspects of ESWL and is intended to serve as an aid to any urologist
performing ESWL. The literature section lists various review articles that are
recommended for further reading.
9 Literature
49
9 Literature
[1] C. Chaussy, W. Brendel et al. Extracorporeally induced destruction
of kidney stones by shockwaves. Lancet 316: 1265-8, 1980.
[2] G.G. Tailly. Lithotripsy Systems. In A.D. Smith, G.H. Badlani et
al. (Eds.) Smiths textbook of Endourology (3rd Edition). WileyBlackwell, 2012, pp 559-575.
[3] A.M. Loske. Shock wave physics for urologists. Mexico: Universidad
Nacional Autnoma de Mxico. ISBN: 978-970-32-4377-8.
[4] R.O. Cleveland, J.A. McAteer. Physics of shock-wave lithotripsy.
In A.D. Smith, G.H. Badlani et al. (Eds.) Smiths textbook of
Endourology (3rd Edition). Wiley-Blackwell, 2012, pp 529-558.
[5] C. Trk, T. Knoll et al. Guidelines on Urolithiasis. European
Association of Urology, 2011.
[6] G.M. Preminger, H.G. Tiselius et al. EAU/AUA Nephrolithiasis
Guideline Panel. 2007 guideline for the management of ureteral
calculi. J Urol 178: 2418-34, 2007.
[7] H.-G. Tiselius, C.G. Chaussy. Aspects on how extracorporeal
shockwave lithotripsy should be carried out in order to be
maximally effective. Urol Res 40: 433-46, 2012.
[8] J.J. Rassweiler, H.-M. Fritsche et al. Extracorporeal shock wave
lithotripsy in the year 2012. In T. Knoll, M.S. Pearle. Clinical
Management of Urolithiasis. Springer, 2013, pp 51-76.
[9] C. Bach, N. Buchholz. Shock wave lithotripsy for renal and ureteric
stones. Eur Urol Suppl. 10: 423-432, 2011.
[10] M.J. Semins, B.R. Matlaga. How to improve results with extra
corporeal shock wave lithotripsy. Ther Adv Urol 1: 99-105, 2009.
[11] A. DAddessi, L. Bongiovanni et al. Extracorporeal shockwave
lithotripsy in pediatrics. J Endourol 22: 1-22, 2008.
[12] A. Hesse, H.G. Tiselius et al. Urinary stones. Diagnosis, treatment
and prevention of recurrence. 3rd Edition. Karger, 2009.
This book, including all parts thereof, is legally protected by copyright. Any use, exploitation,
or commercialization outside the narrow limits set by copyright legislation, without the
publishers consent, is illegal and liable to prosecution. This applies in particular to photostat
reproduction, copying, mimeographing, preparation of microfilms, and electronic data
processing and storage.
Insofar as this book mentions any dosage or application, readers may rest assured that the
authors, editors and publishers have made every effort to ensure that such references are in
accordance with the state of knowledge at the time of production of the book.
Nevertheless, this does not involve, imply, or express any guarantee or responsibility on
the part of the publishers in respect to any dosage instructions and forms of applications
stated in the book. Every user is requested to examine carefully the manufacturers leaflets
accompanying each drug or system and to check, if necessary in consultation with a physician
or specialist, whether the dosage schedules mentioned therein or the contraindications stated
by the manufacturers differ from the statements made in the present book. Every dosage
schedule or every form of application used is entirely at the users own risk and responsibility.
The authors and publishers request every user to report to the publishers any discrepancies or
inaccuracies noticed.
Some of the product names, patents, and registered designs referred to in this book are in
fact registered trademarks or proprietary names even though specific reference to this fact
is not always made in the text. Therefore, the appearance of a name without designation as
proprietary is not to be construed as a representation by the publisher that it is in the public
domain.